Compare INDRAPRASTHA MEDICAL with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs NARAYANA HRUDAYALAYA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL NARAYANA HRUDAYALAYA INDRAPRASTHA MEDICAL/
NARAYANA HRUDAYALAYA
 
P/E (TTM) x 17.6 57.4 30.6% View Chart
P/BV x 2.8 9.7 29.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 INDRAPRASTHA MEDICAL   NARAYANA HRUDAYALAYA
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-20
NARAYANA HRUDAYALAYA
Mar-21
INDRAPRASTHA MEDICAL/
NARAYANA HRUDAYALAYA
5-Yr Chart
Click to enlarge
High Rs52524 10.0%   
Low Rs27239 11.5%   
Sales per share (Unadj.) Rs90.6126.4 71.7%  
Earnings per share (Unadj.) Rs4.8-0.4 -1,304.2%  
Cash flow per share (Unadj.) Rs8.48.6 97.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs29.254.6 53.5%  
Shares outstanding (eoy) m91.67204.36 44.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.43.0 14.6%   
Avg P/E ratio x8.4-1,045.3 -0.8%  
P/CF ratio (eoy) x4.844.3 10.8%  
Price / Book Value ratio x1.47.0 19.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,66077,948 4.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1396,272 34.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,30825,823 32.2%  
Other income Rs m7282 2.4%   
Total revenues Rs m8,31526,105 31.9%   
Gross profit Rs m8641,885 45.8%  
Depreciation Rs m3301,835 18.0%   
Interest Rs m59823 7.2%   
Profit before tax Rs m482-492 -97.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46-418 -10.9%   
Profit after tax Rs m436-75 -585.0%  
Gross profit margin %10.47.3 142.5%  
Effective tax rate %9.584.9 11.2%   
Net profit margin %5.3-0.3 -1,818.4%  
BALANCE SHEET DATA
Current assets Rs m1,4156,651 21.3%   
Current liabilities Rs m1,3967,032 19.9%   
Net working cap to sales %0.2-1.5 -15.2%  
Current ratio x1.00.9 107.1%  
Inventory Days Days233 6.5%  
Debtors Days Days3539 88.3%  
Net fixed assets Rs m3,07521,031 14.6%   
Share capital Rs m9172,044 44.9%   
"Free" reserves Rs m1,7619,122 19.3%   
Net worth Rs m2,67811,165 24.0%   
Long term debt Rs m05,041 0.0%   
Total assets Rs m4,49027,682 16.2%  
Interest coverage x9.10.4 2,273.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.90.9 198.3%   
Return on assets %11.02.7 407.8%  
Return on equity %16.3-0.7 -2,439.1%  
Return on capital %20.22.0 988.7%  
Exports to sales %00-   
Imports to sales %00.1 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA29 0.0%   
Fx inflow Rs m1,408560 251.3%   
Fx outflow Rs m34484 410.8%   
Net fx Rs m1,064477 223.2%   
CASH FLOW
From Operations Rs m8653,091 28.0%  
From Investments Rs m-402-1,130 35.6%  
From Financial Activity Rs m-427-1,984 21.5%  
Net Cashflow Rs m35-23 -150.4%  

Share Holding

Indian Promoters % 49.4 63.9 77.4%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 0.0 30.2 0.1%  
FIIs % 0.0 10.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 36.2 135.5%  
Shareholders   59,093 44,526 132.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   KRSNAA DIAGNOSTICS  CONSTRONICS INFRA  DR LALCHANDANI LABS  METROPOLIS HEALTHCARE  KAYA  



Today's Market

Indian Indices End Flat; Nestle, HDFC and ICICI Bank Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

NARAYANA HRUDAYALAYA Announces Quarterly Results (1QFY22); Net Profit Up 165.4% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, NARAYANA HRUDAYALAYA has posted a net profit of Rs 777 m (up 165.4% YoY). Sales on the other hand came in at Rs 9 bn (up 118.5% YoY). Read on for a complete analysis of NARAYANA HRUDAYALAYA's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

More Views on News

Most Popular

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Sep 22, 2021 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - ASTER DM HEALTHCARE COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS